Increase in Antidepressant Medication in the US Adult Population between 1990 and 2003
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background: The rate of antidepressant treatment in the US has significantly increased in the past decade. There are, however, concerns about undertreatment among traditionally underserved groups and overtreatment in less severely ill individuals. This study examines trends in the prevalence of antidepressant drug treatment in two US general population surveys. Methods: The prevalence of antidepressant treatment within a 12-month period was compared in the US National Comorbidity Survey (1990–1992) and the National Comorbidity Survey-Replication (2001–2003). Variations in trends across groups were examined using bivariate and multivariate logistic regression models. Results: The rate of antidepressant drug treatment increased more than four times between early 1990s and early 2000s. The trend was similar across sociodemographic groups. Younger adults, men and racial/ethnic minorities continued to receive antidepressant treatment at a lower rate compared to middle-aged adults, women and non-Hispanic whites, respectively. The rate of antidepressant treatment increased more in the group of less severely ill individuals than in those with more severe psychopathology. Conclusions: Sociodemographic disparities in antidepressant treatment persisted over the last decade in the US, lending support to concerns about undertreatment among traditionally underserved groups, whereas the greater increase in the rate of antidepressant treatment in the less severely ill group lends support to concerns about antidepressant overtreatment in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These changes in attitudes were matched by significant increases in the use of mental health services in recent years (20-25).”
From Attitudes toward mental health help seeking as predictors of future help-seeking behavior and use of mental health treatments (2016) · cites this paper as [22]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327 · cited 1×
“The items covered depressed mood, loss of interest, hopelessness, trouble concentrating, inappropriate guilt or feelings of worthlessness, lack of energy, worrying too much, feeling tense, feeling ‘trapped’, and feeling lonely. The respondents were asked to rate the frequency of each symptom over the past 30 days on a…”
MethodInfluentialKessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Screening for serious mental illness in the general population
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S.-L. T., Manderscheid, R. W., Walters, E. E., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.184 · Cited by 5,692
Mental Health: A Report of the Surgeon General
(1999) · PsycEXTRA Dataset · doi:10.1037/e636982009-001 · Cited by 3,097
Wittchen, H.-U. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90036-1 · Cited by 2,348
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910 · cited 1×
“corresponding to the following definitions of impairment: (1) lost days: the number of days in which the respondent was ‘totally unable to work or carry out normal activities’, (2) cutback days: the number of days in which the respondent had to ‘cut down’ on what he/she did or ‘did not get as much done as usual’, and…”
BackgroundKessler, R. C. (2005) · JAMA · doi:10.1001/jama.293.20.2487 · Cited by 1,073 · cited 1×
“Suicidality was assessed by presenting the participants with a list of different experiences including thinking seriously about suicide, making a plan for committing suicide and attempting suicide. Reports of any of these experiences in the past 12 months were rated as a positive rating of suicidality. Previous report…”
Method
Research works printed but not linked: 2
- 10.1176%2Fappi.ajgp.10.3.256 · doi:10.1176/appi.ajgp.10.3.256
- 10.1176%2Fappi.ajp.163.7.1187 · doi:10.1176/appi.ajp.163.7.1187 · Paper page
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,520
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
Jorm, A. F., Patten, S. B., Brugha, T. S., & Mojtabai, R. (2017) · World Psychiatry · doi:10.1002/wps.20388 · Cited by 556
Self-citationNational Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
Mojtabai, R., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.175 · Cited by 479
Self-citationNational trends in the treatment for depression from 1998 to 2007
Marcus, S. C., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.151 · Cited by 312
Berman, R. M., Fava, M., Thase, M. E., Trivedi, M. H., Swanink, R., McQuade, R. D., Carson, W. H., Adson, D., Taylor, L., Hazel, J., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900020216 · Cited by 260
Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing
Mojtabai, R., & Olfson, M. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.1024 · Cited by 256
Self-citationSmoller, J. W. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.436 · Cited by 255
The Association Between Air Pollution and Onset of Depression Among Middle-Aged and Older Women
Kioumourtzoglou, M.-A., Power, M. C., Hart, J. E., Okereke, O. I., Coull, B. A., Laden, F., & Weisskopf, M. G. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww163 · Cited by 214
Unmet Need for Treatment of Major Depression in the United States
Mojtabai, R. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.3.297 · Cited by 193
Self-citationMojtabai, R., Evans-Lacko, S., Schomerus, G., & Thornicroft, G. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500164 · Cited by 160
Self-citationDoes Study Design Influence Outcome?
Rutherford, B. R., Sneed, J. R., & Roose, S. P. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209348 · Cited by 158
“analyzed data from 47 RCTs of antidepressants submitted to the FDA for marketing approval, finding a mean improvement of 9.60 points on the HRSD in the drug group compared to 7.80 in the placebo groups. The response to placebo therefore duplicated >80p of the change found in the drug groups, and the difference between…”
InfluentialMojtabai, R., & Jorm, A. F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.039 · Cited by 138
Self-citationAssociation of Cerebrovascular Events With Antidepressant Use: A Case-Crossover Study
Wu, C.-S., Wang, S.-C., Cheng, Y.-C., & Gau, S. S.-F. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10071064 · Cited by 137
Renoux, C., Vahey, S., Dell’Aniello, S., & Boivin, J.-F. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4529 · Cited by 135
Lockhart, P., & Guthrie, B. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x593848 · Cited by 123
Pan, A., Sun, Q., Okereke, O. I., Rexrode, K. M., Rubin, R. R., Lucas, M., Willett, W. C., Manson, J. E., & Hu, F. B. (2012) · Diabetologia · doi:10.1007/s00125-011-2268-4 · Cited by 117
“The prevalence of ADM use over time in our studies was consistent with several national datasets [1, 28].”
Age and Sex Patterns of Drug Prescribing in a Defined American Population
Zhong, W., Maradit-Kremers, H., St. Sauver, J. L., Yawn, B. P., Ebbert, J. O., Roger, V. L., Jacobson, D. J., McGree, M. E., Brue, S. M., & Rocca, W. A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.04.021 · Cited by 116
Mojtabai, R. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345968 · Cited by 101
Self-citationHow an Age of Anxiety Became an Age of Depression
Horwitz, A. V. (2010) · Milbank Quarterly · doi:10.1111/j.1468-0009.2010.00591.x · Cited by 132
“population was using an antidepressant (Mojtabai 2008).”
A guide to the treatment of depression in women by estrogens
Studd, J. W. (2011) · Climacteric · doi:10.3109/13697137.2011.609285 · Cited by 66
Antidepressant medication use and breast cancer risk
Wernli, K. J., Hampton, J. M., Trentham‐Dietz, A., & Newcomb, P. A. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1719 · Cited by 64
Nishi, D., Susukida, R., Usuda, K., Mojtabai, R., & Yamanouchi, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.016 · Cited by 64
Self-citationFischer, M. J., Xie, D., Jordan, N., Kop, W. J., Krousel-Wood, M. A., Tamura, M. K., Kusek, J. W., Ford, V., Rosen, L. K., Strauss, L., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.033 · Cited by 71
Americans' Attitudes Toward Psychiatric Medications: 1998–2006
Mojtabai, R. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.8.1015 · Cited by 57
Self-citationMajor Depression, Antidepressant Medication and the Risk of Obesity
Patten, S. B., Williams, J. V. A., Lavorato, D. H., Brown, L., McLaren, L., & Eliasziw, M. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209349 · Cited by 57
von Soest, T., Bramness, J. G., Pedersen, W., & Wichstrøm, L. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000722 · Cited by 61
“The rate of antidepressant treatment in the adult population, for instance, rose more than three times between the early 1990s and the early 2000s in the United States (Mojtabai, 2008), Great Britain (Brugha et al. 2004) and the Nordic countries (Isacsson, 2000; Bramness et al. 2007).”
BackgroundHorwitz, A. V. (2011) · Society and Mental Health · doi:10.1177/2156869310393986 · Cited by 55
“By 2000, the antidepressants were the best-selling category of drugs of any sort in the United States; fully 10 percent of the U.S. population was using an antidepressant (Mojtabai 2008).”
BackgroundPrescribing of Psychotropic Medications to Patients Without a Psychiatric Diagnosis
Wiechers, I. R., LESLIE, D. L., & Rosenheck, R. A. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200557 · Cited by 45
Prescription patterns of antidepressants: findings from a US claims database
Milea, D., Verpillat, P., Guelfucci, F., Toumi, M., & Lamure, M. P. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003772096 · Cited by 45
“Enrolment and claims data were extracted from this extraction for enrolees of any age who fulfilled the following criteria (Figure 1): (1) at least one reimbursement claim for one of the following antidepressant drugs: bupropion (not when indicated for smoking cessation), citalopram, duloxetine, escitalopram, fluoxeti…”
MethodDouros, A., Ades, M., & Renoux, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0507-7 · Cited by 42
Metsä‐Simola, N., & Martikainen, P. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.06.027 · Cited by 48
“In the past 25 years the rate of treatment has increased more among the less severely ill (Brugha et al., 2004; Mojtabai, 2008).”
BackgroundTakayanagi, Y., Spira, A. P., Bienvenu, O. J., Hock, R. S., Carras, M. C., Eaton, W. W., & Mojtabai, R. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08824 · Cited by 39
Self-citationZhang, X., Zhang, Y., & Zhai, J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.740187 · Cited by 53
Haller, E., Watzke, B., Blozik, E., Rosemann, T. J., Reich, O., Huber, C. A., & Wolf, M. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2178-4 · Cited by 39
Wiechers, I. R., Kirwin, P. D., & Rosenheck, R. A. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.10.007 · Cited by 35
Erie, J. C., Brue, S. M., Chamberlain, A. M., & Hodge, D. O. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.03.006 · Cited by 36
Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal
Massabki, I., & Abi-Jaoude, E. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.269 · Cited by 33
Butterworth, P., Olesen, S. C., & Leach, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.006 · Cited by 36
The Decline of Pharmaceutical Psychiatry and the Increasing Role of Psychological Medicine
Fava, G. A. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000214443 · Cited by 36
“had warned in the early 80s, while anticipating the rise in antidepressant consumption [”
BackgroundThe Biobehavioral Family Model: Testing Social Support as an Additional Exogenous Variable
Woods, S., Priest, J. B., & Roush, T. R. (2014) · Family Process · doi:10.1111/famp.12086 · Cited by 36
“The NCS-R included 14 items assessing for significant mental health symptoms, drawn from the Hopkins Symptom Checklist-25 (HSC-25; Derogatis, Lipman, Rickels, Uhlenhuth, & Covi, 1974; Kessler et al., 1999; Mojtabai, 2008).”
MethodThe 6-month persistence on SSRIs and associated economic burden
Ereshefsky, L., Saragoussi, D., Despiégel, N., Hansen, K., François, C., & Maman, K. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.511050 · Cited by 35
“All regressions were adjusted on the following covariates: (1) patient demographics (i.”
MethodZhong, W., Kremers, H. M., Yawn, B. P., Bobo, W. V., St. Sauver, J. L., Ebbert, J. O., Finney Rutten, L. J., Jacobson, D. J., Brue, S. M., & Rocca, W. A. (2014) · Archives of Women's Mental Health · doi:10.1007/s00737-014-0450-7 · Cited by 28
“AD prescriptions increased steadily from 2005 to 2011, similar to trends observed in previous studies from earlier time frames (Mojtabai 2008; Olfson and Marcus 2009).”
Trends in the epidemiology of depression and comorbidities from 2000 to 2019 in Belgium
Walrave, R., Beerten, S. G., Mamouris, P., Coteur, K., Nuland, M. V., Pottelbergh, G. V., Casas, L., & Vaes, B. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01769-w · Cited by 38
Comparing Homicide‐Suicides in the United States and Sweden
Regoeczi, W. C., Granath, S., Issa, R., Gilson, T. P., & Sturup, J. (2016) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13194 · Cited by 27
Patterns of serotonergic antidepressant usage in prodromal Huntington disease
Rowe, K. C., Paulsen, J. S., Langbehn, D. R., Wang, C., Mills, J. A., Beglinger, L. J., Smith, M. M., Epping, E. A., Fiedorowicz, J. G., Duff, K., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.09.005 · Cited by 29
“Mojtabai (2008) further showed that women were twice as likely to have a current prescription for an antidepressant as men between 2001 and 2003.”
InfluentialRuths, S., Haukenes, I., Hetlevik, Ø., Smith‐Sivertsen, T., Hjörleifsson, S., Hansen, A. B., Riiser, S., Meling, H. M., & Baste, V. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06712-w · Cited by 27
Antidepressant use and glycemic control
Mojtabai, R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2972-5 · Cited by 24
“The favorable side effect profiles of the newer antidepressants, especially the selective serotonin reuptake inhibitors (SSRIs) compared to the older tricyclic antidepressants (TCAs) has likely contributed to their popularity among prescribers and patients (Anderson 2000; Frank and Glied 2006; Mojtabai 2008).”
BackgroundSelf-citationHarris, M., Burgess, P. M., Pirkis, J., Siskind, D. J., Slade, T. N., & Whiteford, H. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.531459 · Cited by 26
Choung, R. S., Locke, G. R., Schleck, C. D., Zinsmeister, A. R., & Talley, N. J. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12082 · Cited by 21
The public health impact of antidepressants: An instrumental variable analysis
Mojtabai, R. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.037 · Cited by 22
Self-citationHormone therapy for reproductive depression in women
Studd, J. W. W. (2014) · Post Reproductive Health · doi:10.1177/2053369114557883 · Cited by 21
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
Arnaud, A. M., Suthoff, E. D., Tavares, R. M., Zhang, X., & Ravindranath, A. J. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01021-w · Cited by 21
Help-Seeking for Emotional Problems in Major Depression: Findings of the 2006 Estonian Health Survey
Kleinberg, A., Aluoja, A., & Vasar, V. (2012) · Community Mental Health Journal · doi:10.1007/s10597-012-9499-9 · Cited by 29
Age, period and cohort effects in firearm homicide and suicide in the USA, 1983–2017
Haviland, M. J., Rowhani-Rahbar, A., & Rivara, F. P. (2021) · Injury Prevention · doi:10.1136/injuryprev-2020-043714 · Cited by 19
Antidepressants and Cdk inhibitors: Releasing the brake on neurogenesis?
Chesnokova, V., & Pechnick, R. N. (2008) · Cell Cycle · doi:10.4161/cc.6446 · Cited by 19
Schofield, M. J., & Khan, A. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0896-y · Cited by 19
Mojtabai, R. (2011) · Medical Care Research and Review · doi:10.1177/1077558710388290 · Cited by 17
“For example, while 70% of patients who reported taking antidepressants in a survey in the early 1990s met the criteria for mood or anxiety disorders, only 54% did so in another survey in early 2000s (Mojtabai, 2008).”
BackgroundSelf-citationPsychiatry’s Continuing Expansion of Depressive Disorder
Wakefield, J. C., & Horwitz, A. V. (2015) · History, philosophy and theory of the life sciences · doi:10.1007/978-94-017-7423-9_12 · Cited by 19
Yang, Z., Zhao, X., Zhu, L., Xia, Y., Ma, Y., Wu, J., Xiong, X., Yang, N., & Miao, L. (2023) · Land · doi:10.3390/land12071317 · Cited by 20
Renoux, C., Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J., Tamim, H., Mahmud, S. M., Alsabbagh, M. W., Hemmelgarn, B. R., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11271114 · Cited by 19
Wemakor, A., Casson, K., & Dolk, H. M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.015 · Cited by 25
Racial Differences in Antidepressant Use Among Older Home Health Care Patients
Pickett, Y. R., Weissman, J. D., & BRUCE, M. L. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100233 · Cited by 14
Lakey, S. L., Gray, S. L., Ciechanowski, P. S., Schwartz, S. J., & LoGerfo, J. P. (2008) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2008.03.004 · Cited by 12
How Did Everyone Get Diagnosed with Major Depressive Disorder?
Horwitz, A. V. (2015) · Perspectives in biology and medicine · doi:10.1353/pbm.2015.0005 · Cited by 11
Pathways to Care: Need, Attitudes, Barriers
Mojtabai, R., Eaton, W. W., & Maulik, P. K. (2012) · Public Mental Health · doi:10.1093/acprof:oso/9780195390445.003.0015 · Cited by 10
Self-citationThe adverse effects of commonly used medications on male fertility: a comprehensive review
Ghomeshi, A., Yang, B., & Masterson, T. A. (2023) · F&S Reviews · doi:10.1016/j.xfnr.2023.08.001 · Cited by 15
Primary Mental Healthcare and Integrated Services
Fleury, M., & Grenier, G. (2012) · InTech eBooks · doi:10.5772/31262 · Cited by 10
“1% in 2001-2003 (Mojtabai, 2008); in New Zealand, from 7.”
InfluentialSocial Context, Biology, and the Definition of Disorder
Horwitz, A. V. (2017) · Journal of Health and Social Behavior · doi:10.1177/0022146517705165 · Cited by 10
Verdú, E. S., Fraile, J. S., Larrea, V. P., & Vicens, C. (2014) · Atención Primaria · doi:10.1016/j.aprim.2013.11.006 · Cited by 22
van den Boogaard, T. M., Verhaak, P. F. M., van Dyck, R., & Spinhoven, P. (2011) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.09.027 · Cited by 7
Löfman, S., Hakko, H. H., Mainio, A., & Riipinen, P. K. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.05.031 · Cited by 11
Kumar, S., Tran, J. L., Ramirez, E. R., Lee, W.-N., Foschini, L., & Juusola, J. L. (2020) · JMIR Mental Health · doi:10.2196/17075 · Cited by 9
Pattern of psychotropic medication use over two decades in Australian women
Stuart, A. L., Mohebbi, M., Pasco, J. A., Quirk, S. E., Brennan-Olsen, S. L., Berk, M., & Williams, L. J. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417704056 · Cited by 7
“…literature using prescription and physician databases (Hollingworth et al., 2010a; Ilyas and Moncrieff, 2012; McManus et al., 2000; Stephenson et al., 2013) and US nationally representative surveys (Han et al., 2016; Mojtabai, 2008; Paulose-Ram et al., 2007; Olfson and Marcus, 2009; Zuvekas, 2005).”
Method‘PROFOX’ – the post HRT nightmare
Studd, J. W. W. (2010) · Climacteric · doi:10.3109/13697137.2010.529199 · Cited by 6
Behavioral Consultation and Primary Care: The “Why Now?” and “How?”
Robinson, P. J., & Reiter, J. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-13954-8_1 · Cited by 7
Os efeitos na formação de residentes de psiquiatria ao experimentarem grupos GAM
Otanari, T. M. D. C., Leal, E. M., Campos, R. T. O., Palombini, A. D. L., & Pereira, E. H. P. (2011) · Revista Brasileira de Educação Médica · doi:10.1590/s0100-55022011000400004 · Cited by 4
Amendola, S., & Hengartner, M. P. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000522 · Cited by 5
“While depression and anxiety were – and still are – undertreated in certain groups of seriously ill people (Kessler et al ., 2005; Mojtabai, 2008; Olfson et al. , 2016), there is now compelling evidence that a much larger group of people, especially those with mild and subthreshold depression,…”
BackgroundUtilização de serviços de saúde mental em Portugal em tempos de crise económica
Cardoso, G., Loureiro, A., Mateus, P., Silva, M., Santana, P., & Caldas‐de‐Almeida, J. M. (2015) · Imprensa da Universidade de Coimbra eBooks · doi:10.14195/978-989-26-1105-1_6 · Cited by 2
“tratamentos específicos Duas investigações feitas a nível da população geral nos EUA mostraram que o rendimento familiar não estava associado com a utilização de antidepressivos no tratamento de pessoas diagnosticadas com depressão (Mojtabai, 2008).”
BackgroundDepression and antidepressants in Australia and beyond: A critical public health analysisPreprint
Raven, M. K. (2018) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/7wue6 · Cited by 2
The Primary Care Behavioral Health Model: The “Why Now?” and “How?” (Updated!)
Robinson, P. J., & Reiter, J. T. (2025) · Springer eBooks · doi:10.1007/978-3-031-72150-2_1 · Cited by 1
Lee, K. H., Park, G., Bahk, W., Lee, S.-J., & Pae, C. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.3.445 · Cited by 1
Pathways to Care: Need, Attitudes, Barriers
Mojtabai, R., Murray, S., & Eaton, W. W. (2019) · Oxford University Press eBooks · doi:10.1093/oso/9780190916602.003.0017 · Cited by 2
Self-citationCollins, J. M., & Schmeiser, M. D. (2010) · SSRN Electronic Journal · doi:10.2139/ssrn.1559957 · Cited by 1
Targeting depressive symptoms is unlikely to help
Coyne, J. C. (2010) · BMJ · doi:10.1136/bmj.c4697
Utilização de psicofármacos pela população geral residente na região metropolitana de São Paulo
Campanha, A. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-09062015-153011 · Cited by 1
Understanding Health Talk in Behavioral Health Encounters: A Qualitative Analysis
Matthews, E. B., Bond, L., & Stanhope, V. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01088-1
GPs’ drug treatment for depression by patients’ educational level: registry-based study
Hansen, A. B., Baste, V., Hetlevik, Ø., Haukenes, I., Smith‐Sivertsen, T., & Sabine, R. (2020) · BJGP Open · doi:10.3399/bjgpo.2020.0122 · Cited by 12
Current awareness in human psychopharmacology
(2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.891
Current awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1489
Antidepressant use in Turkey by provinces: panel data analysis
Oğuzhan, G. E., Eren, M., Kockaya, G., Baskı, K. A., Şaylan, M., KURNAZ, M., & Ökçün, S. (2022) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmac006
Breaking free: Navigating antidepressant withdrawal
Hannah, M., & Abi‐Jaoude, E. (2024) · Indian Journal of Medical Ethics · doi:10.20529/ijme.2023.038
Väänänen, A. (2024) · Policy Press eBooks · doi:10.51952/9781447359456.bm002
Ruths, S., Haukenes, I., Hetlevik, Ø., Smith‐Sivertsen, T., Hjörleifsson, S., Hansen, A. B., Riiser, S., Meling, H. M., & Baste, V. (2021) · Figshare · doi:10.6084/m9.figshare.14992778
Walrave, R., Beerten, S. G., Mamouris, P., Coteur, K., Nuland, M. V., Pottelbergh, G. V., Casas, L., & Vaes, B. (2022) · Figshare · doi:10.6084/m9.figshare.20176115
Fisher, K. G., Leach, O. K., Greaney, J. L., Alexander, L. M., & Kenney, W. L. (2026) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00147.2026
Nigatu, Y. T., Imtiaz, S., Rueda, S., Elton‐Marshall, T., & Hamilton, H. A. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342261462867
Karami, S., Ventura, C., Pinnow, E. E., Dwumfour, N., Asonye, A., Pan, G. D., & Zhou, E. H. (2026) · Journal of Medical Toxicology · doi:10.1007/s13181-026-01159-z
“Females may be more likely to use nonprescription DXM-containing products for their intended therapeutic purpose (cough suppression) [38, 56, 57], making them more susceptible to therapeutic errors, particularly when managing symptoms of COVID-19 or other respiratory illnesses without clinical…”
Metadata
- Authors
- Mojtabai, R.
- Affiliations
- Mount Sinai Beth Israel (US)
- Corresponding author
- Mojtabai, Ramin
- ORCID
- Mojtabai, Ramin
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 77
- Issue
- 2
- Pages
- 83-92
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2093923613
- Cited by
- 100
- References
- 44
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 15.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, sociodemographic disparities, underserved populations, depression, psychopathology severity, National Comorbidity Survey, National Comorbidity Survey Replication, racial and ethnic minorities, gender differences, age differences
- MeSH terms
- Adolescent, Adult, Antidepressive Agents, Cross-Sectional Studies, Depressive Disorder, Major, Major Depressive Disorder, Drug Therapy, Drug Utilization, Female, Humans, Male, Middle Aged, Population Surveillance, Socioeconomic Factors, United States, Incidence, Selective Serotonin Reuptake Inhibitors, Health Care Surveys
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.